Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Still fighting 40 years on - a rich pipeline to combat the complexity of cancer

This article was originally published in Scrip

Executive Summary

December will mark the 40th anniversary of the launch of US President Richard Nixon's "War on Cancer". In retrospect, the unbridled optimism underpinning its noble aims seems somewhat naive. The parallels Nixon drew with the earlier achievements in space travel demonstrate how little was understood of the battle ahead. Reaching the moon had been accomplished by focusing money and intellect on what were, in essence, engineering challenges framed by well-defined and stable physical laws. In contrast, the major lesson from the intervening 40 years in oncology research has been the gradual and hard-won realization of how little of cancer biology is understood and how badly this lack of knowledge impedes the rational design of new therapies.

You may also be interested in...

Oncology Scorecard – Who’s Succeeding At Cancer Drug Development

Using Pharmapremia data, we analyze performance metrics for a select group of leading cancer companies to see where the sticking points are and who is winning at industry’s most important race.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts